Q1 2017 Xencor Inc Earnings Call

9/5/2017 16:30

Conference Call Xencor Inc

Xencor Inc Conference call or earnings call will be held on May 9, 2017 During the earnings conference call's session Xencor Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Xencor Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a clinical­stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody therapeutics to treat severe and life­threatening diseases with unmet medical needs. We use our proprietary XmAb® technology platform to create next­generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer and other conditions. In contrast to conventional approaches to antibody design, which focus on the portion of antibodies that interact with target antigens, we focus on the portion of the antibody that interacts with multiple segments of the immune system and controls antibody structure. This portion, referred to as the Fc domain, is constant and interchangeable among antibodies. Our engineered Fc domains, the XmAb technology, can be readily substituted for natural Fc domains.    
Read more Conference Call

Xencor Inc (XNCR)

111 West Lemon Avenue, Monrovia California 91016, United States